At the time of writing, MBX Biosciences Inc [MBX] stock is trading at $14.57, up 11.82%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MBX shares have gain 24.00% over the last week, with a monthly amount glided 22.33%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
MBX Biosciences Inc [NASDAQ: MBX] stock has seen the most recent analyst activity on July 16, 2025, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $38. Previously, Citizens JMP started tracking the stock with Mkt Outperform rating on April 10, 2025, and set its price target to $38. On October 08, 2024, Stifel initiated with a Buy rating and assigned a price target of $40 on the stock. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $30 on October 08, 2024. Jefferies initiated its recommendation with a Buy and recommended $35 as its price target on October 08, 2024. Guggenheim started tracking with a Buy rating for this stock on October 08, 2024, and assigned it a price target of $44.
For the past year, the stock price of MBX Biosciences Inc fluctuated between $4.81 and $27.50. Currently, Wall Street analysts expect the stock to reach $44 within the next 12 months. MBX Biosciences Inc [NASDAQ: MBX] shares were valued at $14.57 at the most recent close of the market. An investor can expect a potential return of 201.99% based on the average MBX price forecast.
Analyzing the MBX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.44 and Total Capital is -0.35. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.62 points at the first support level, and at 10.68 for the second support level. However, for the 1st resistance point, the stock is sitting at 16.22, and for the 2nd resistance point, it is at 17.87.
Ratios To Look Out For
It is important to note that MBX Biosciences Inc [NASDAQ:MBX] has a current ratio of 23.31. Further, the Quick Ratio stands at 23.31, while the Cash Ratio is 2.85.
Transactions by insiders
Recent insider trading involved Pescovitz Ora H., Director, that happened on Apr 08 ’25 when 7693.0 shares were purchased. Director, GORDON CARL L completed a deal on Feb 18 ’25 to buy 0.14 million shares. Meanwhile, Director GORDON CARL L bought 47502.0 shares on Feb 14 ’25.
